LWCFA
AGN

Loring Wolcott & Coolidge Fiduciary Advisors’s Allergan plc AGN Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-100
Closed -$18K – 678
2020
Q1 		$18K Sell
100
-175
-64% -$33K ﹤0.01% 481
2019
Q4 		$53K Hold
275
– – ﹤0.01% 415
2019
Q3 		$46K Sell
275
-35
-11% -$5.7K ﹤0.01% 416
2019
Q2 		$52K Hold
310
– – ﹤0.01% 402
2019
Q1 		$45K Hold
310
– – ﹤0.01% 411
2018
Q4 		$41K Sell
310
-219
-41% -$35.9K ﹤0.01% 435
2018
Q3 		$101K Sell
529
-989
-65% -$182K ﹤0.01% 349
2018
Q2 		$253K Buy
1,518
+394
+35% +$63.3K ﹤0.01% 252
2018
Q1 		$189K Buy
1,124
+989
+733% +$166K ﹤0.01% 281
2017
Q4 		$22K Sell
135
-2,272
-94% -$408K ﹤0.01% 513
2017
Q3 		$493K Sell
2,407
-13
-0.5% -$3.02K 0.01% 196
2017
Q2 		$611K Buy
2,420
+13
+0.5% +$3.06K 0.01% 183
2017
Q1 		$575K Sell
2,407
-24
-1% -$5.59K 0.01% 185
2016
Q4 		$511K Sell
2,431
-1,065
-30% -$221K 0.01% 189
2016
Q3 		$805K Buy
3,496
+964
+38% +$236K 0.02% 162
2016
Q2 		$585K Buy
2,532
+85
+3% +$19.6K 0.01% 177
2016
Q1 		$656K Sell
2,447
-14
-0.6% -$4.01K 0.02% 166
2015
Q4 		$769K Sell
2,461
-3
-0.1% -$893 0.02% 168
2015
Q3 		$748K Hold
2,464
– – 0.02% 171
2015
Q2 		$748K Sell
2,464
-13
-0.5% -$3.88K 0.02% 171
2015
Q1 		$737K Buy
2,477
+2,268
+1,085% +$647K 0.02% 174
2014
Q4 		$54K Sell
209
-5
-2% -$1.25K ﹤0.01% 419
2014
Q3 		$52K Sell
214
-86
-29% -$19.2K ﹤0.01% 407
2014
Q2 		$67K Hold
300
– – ﹤0.01% 404
2014
Q1 		$62K Buy
+300
New +$59.4K ﹤0.01% 394

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's AGN Position: Q2 2020 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 100 shares — an estimated $18K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in AGN in Q1 2014 and held it in 25 quarters. The position peaked at $805K in Q3 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 100 Allergan plc shares in Q2 2020, an estimated $18K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Allergan plc in Q1 2014 and held it in 25 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Allergan plc position peaked at $805K in Q3 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2020, filed 30 Jul 2020.